This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 May;18(5):561-562.

doi: 10.1016/S1470-2045(17)30188-2. Epub 2017 Mar 15.

Immune-checkpoint inhibition for digestive cancers

Sylvain Manfredi¹, Antoine Drouillard²

Affiliations

Affiliations

¹ Hepato-Gastroenterology and Digestive Oncology Department, Digestive Cancer Registry, University Hospital Dijon, INSERM U866, Dijon 21000, France. Electronic address: sylvain.manfredi@chu-dijon.fr.
² Hepato-Gastroenterology and Digestive Oncology Department, Digestive Cancer Registry, University Hospital Dijon, INSERM U866, Dijon 21000, France.

PMID: 28314687
DOI: 10.1016/S1470-2045(17)30188-2

Comment

Immune-checkpoint inhibition for digestive cancers

Sylvain Manfredi et al. Lancet Oncol. 2017 May.

. 2017 May;18(5):561-562.

doi: 10.1016/S1470-2045(17)30188-2. Epub 2017 Mar 15.

Authors

Sylvain Manfredi¹, Antoine Drouillard²

Affiliations

¹ Hepato-Gastroenterology and Digestive Oncology Department, Digestive Cancer Registry, University Hospital Dijon, INSERM U866, Dijon 21000, France. Electronic address: sylvain.manfredi@chu-dijon.fr.
² Hepato-Gastroenterology and Digestive Oncology Department, Digestive Cancer Registry, University Hospital Dijon, INSERM U866, Dijon 21000, France.

PMID: 28314687
DOI: 10.1016/S1470-2045(17)30188-2

No abstract available

PubMed Disclaimer

Comment on

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial.
Kudo T, Hamamoto Y, Kato K, Ura T, Kojima T, Tsushima T, Hironaka S, Hara H, Satoh T, Iwasa S, Muro K, Yasui H, Minashi K, Yamaguchi K, Ohtsu A, Doki Y, Kitagawa Y. Kudo T, et al. Lancet Oncol. 2017 May;18(5):631-639. doi: 10.1016/S1470-2045(17)30181-X. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314688 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations